Exhaled Nitric Oxide : Biomarker of Acute Respiratory Distress Syndrome

University Hospital, Grenoble20 enrolled

Overview

The aim of the study is to see if endogenous exhaled Nitric Oxyde (eNO) concentrations measured are significantly higher in ARDS patients admitted in ICU ; compared to control subjects in good health with no lung disease or global inflammation, operated under general anesthesia (i.e. intubated and ventilated) for thyroid or parathyroid.

The measurement of endogenous exhaled NO is monitored using a laser spectrometer machine connected to the expiratory circuit of the respirator. The measure is non-invasive and made by sampling expiratory gaz like for capnography. In control subjects, the measurement period corresponds to the first ten minutes after induction of anesthesia (with intubation) before surgical incision. In ARDS patients in intensive care, the measurement of eNO is made in the first twenty-four hours after intubation and ventilation of the patient with mechanical respirator. The primary endpoint is a significantly higher eNO concentration in patients suffering from Acute Respiratory Distress Syndrome (ARDS). Secondary endpoints will assess correlations between eNO concentrations and usual ARDS severity criteria: PaO2/FiO2; ventilator-free days; length of stay in intensive care and all-cause hospital mortality at 30 days.

Study Type

OBSERVATIONAL

Enrollment

Conditions

ARDS, Human Nitric Oxyde

Interventions

Non invasive measure of endogenous exhaled Nitric Oxyde in exhaled gaz, by a laser spectrometerOTHER

A sample of exhaled gases is taken from the expiratory part of the respirator circuit (same way as a capnometry measurement). A laser spectrometer continuously and non-invasively monitors online the concentrations of endogenous NO exhaled by patients.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * For ARDS patients : * Patients with ARDS (according to the Berlin criteria) admitted in intensive care unit and intubated for less than 24 hours. * For control patients : * Patients with no major disease (classified 1 or 2 in the classification of the American Society of Anaesthesiology) * Patients undergoing general anaesthesia for a thyroïd or parathyroïd surgery Exclusion Criteria: * Minors under the age of 18 years old * Pregnant women * prisoners * patients who have withdrawn their consent.

Locations (1)

CHU Grenoble Alpes

Grenoble, France

Outcomes

Primary Outcomes

Endogenous exhaled Nitric Oxyde (eNO)

The primary endpoint is a significantly higher eNO concentration in ARDS patients.

Time frame: Measurement of eNO over a period of 10 minutes just after induction of anesthesia

Secondary Outcomes

Secondary endpoints will assess correlations between eNO concentrations and usual ARDS severity criteria

ARDS severity criteria are: Partial arterial pressure of oxygen divided by inspired fraction of oxygen (PaO2/FiO2); ventilator-free days; length of stay in intensive care and all-cause hospital mortality at 30 days.

Time frame: Measurement of eNO over a period of 10 minutes within the first 24 hours after intubation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.